Incruse Ellipta - Uses, Dosage, Side Effects

Incruse Ellipta is a long-acting muscarinic antagonist (LAMA) used for the maintenance treatment of airflow obstruction in patients with COPD. It helps to relax the muscles around the airways, improving breathing capacity.

Incruse Ellipta FAQ

Image credit: drugs.com

What is Incruse Ellipta used for?

See section 4. Incruse Ellipta contains the active substance umeclidinium bromide, which belongs to a group of medicines called bronchodilators. This medicine is used to treat chronic obstructive pulmonary disease (COPD) in adults.

How do I get Incruse Ellipta?

Incruse Ellipta can only be obtained with a prescription. It is available as an inhalation powder in a portable inhaler device. Each inhalation provides 65 micrograms of umeclidinium bromide equivalent to 55 micrograms of umeclidinium. The recommended dose is one inhalation per day at the same time each day.

Can Incruse Ellipta be used to treat sudden breathing problems?

You shouldn’t use Incruse Ellipta to treat sudden breathing problems. Instead, Incruse Ellipta should be used consistently as a maintenance (long-term) treatment to reduce symptoms of COPD. This drug will not help to treat sudden symptom flare-ups.